Additional Information
Book Details
Abstract
Canine and Feline Infectious Diseases is a practical, up-to-date resource covering the most important and cutting-edge advances in the field. Presented by a seasoned educator in a concise, highly visual format, this innovative guide keeps you current with the latest advances in this ever-changing field. 80 case studies illustrate the clinical relevance of the major infectious disease chapters.
- Well-organized Major Infectious Diseases chapters break down content by etiologic agent and epidemiology, clinical signs and their pathophysiology, physical examination findings, diagnosis, treatment and prognosis, immunity, prevention, and public health implications.
- Over 80 case studies illustrate how the information provided can be applied in everyday practice.
- Logical approach to laboratory diagnosis guides you through all the steps needed to accurately diagnose and treat viral, bacterial, fungal, protozoal, and algal diseases.
- Practical protocols provided by expert clinicians guide you in the management of canine and feline patients suspected to have infectious diseases, including handling, disinfection, isolation, and vaccination protocols.
- Over 500 full color images – geographic distribution maps, life cycle drawings, and hundreds of color photographs – visually illustrate and clarify complex issues.
- Easy-to-understand tables and boxes make content quickly accessible, eliminating the need to sort through dense text for critical information in the clinical setting.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Canine and Feline Infectious Diseases | i | ||
| Copyright | ii | ||
| Contributors | iii | ||
| Dedication | vi | ||
| Preface | vii | ||
| Acknowledgments | viii | ||
| Contents | ix | ||
| Chapter 1 - Isolation in Cell Culture | 1 | ||
| PART I -\rBasic Principles in the Diagnosisand Management of SmallAnimal Infection | 1 | ||
| SECTION 1 -\rLaboratory Diagnosis of Canineand Feline Infectious Diseases | 2 | ||
| Chapter 1 -\x0BIsolation in Cell Culture | 2 | ||
| INTRODUCTION | 2 | ||
| Specimen Collection and Transport | 2 | ||
| Diagnostic Methods | 4 | ||
| Interpretation of Results | 7 | ||
| REFERENCES | 9 | ||
| Chapter 2 - Immunoassays | 10 | ||
| INTRODUCTION | 10 | ||
| Specimen Collection and Transport | 10 | ||
| Diagnostic Methods | 11 | ||
| Interpretation of Results | 14 | ||
| REFERENCES | 16 | ||
| Chapter 3 - Isolation and Identification of Aerobic and Anaerobic Bacteria | 17 | ||
| INTRODUCTION | 17 | ||
| Specimen Collection and Transport | 17 | ||
| Diagnostic Methods | 18 | ||
| Interpretation of Bacterial Culture Results | 23 | ||
| Antimicrobial Susceptibility Testing | 23 | ||
| Dilution Methods | 23 | ||
| Diffusion Methods | 26 | ||
| SUGGESTED READINGS | 28 | ||
| REFERENCES | 28 | ||
| Chapter 4 - Isolation and Identification of Fungi | 29 | ||
| INTRODUCTION AND DEFINITIONS | 29 | ||
| Specimen Collection and Transport | 29 | ||
| Diagnostic Methods | 30 | ||
| Interpretation of Fungal Culture Results | 33 | ||
| Antifungal Susceptibility Testing | 34 | ||
| REFERENCES | 36 | ||
| Chapter 5 - Nucleic Acid Detection Assays | 37 | ||
| INTRODUCTION | 37 | ||
| Specimen Collection and Transport | 37 | ||
| Diagnostic Methods | 39 | ||
| Interpretation of Results | 44 | ||
| REFERENCES | 45 | ||
| SECTION 2 -\rAntiinfective Therapy | 46 | ||
| Chapter 6 - Principles of Antiinfective Therapy | 46 | ||
| INTRODUCTION | 46 | ||
| Identification of the Infecting Organism | 46 | ||
| Classification of Antimicrobial Drugs | 47 | ||
| Pharmacodynamics of Antimicrobial Drugs | 47 | ||
| Site of Infection | 49 | ||
| Other Host Factors | 49 | ||
| Route of Administration | 50 | ||
| Antimicrobial Resistance | 51 | ||
| Antimicrobial Drug Combinations | 52 | ||
| Monitoring the Response to Treatment | 53 | ||
| SUGGESTED READINGS | 53 | ||
| REFERENCES | 53 | ||
| Chapter 7 - Antiviral and Immunomodulatory Drugs | 54 | ||
| INTRODUCTION | 54 | ||
| Antiviral Drugs | 54 | ||
| Immunomodulators | 59 | ||
| SUGGESTED READINGS | 63 | ||
| REFERENCES | 63 | ||
| Chapter 8 - Antibacterial Drugs | 66 | ||
| INTRODUCTION | 66 | ||
| Inhibitors of Cell Wall Synthesis | 66 | ||
| Nucleic Acid Inhibitors | 72 | ||
| Protein Synthesis Inhibitors | 77 | ||
| REFERENCES | 84 | ||
| Chapter 9 - Antifungal Drugs | 87 | ||
| INTRODUCTION | 87 | ||
| Azole Antifungals | 87 | ||
| Amphotericin B | 91 | ||
| 5-Flucytosine | 93 | ||
| Griseofulvin | 93 | ||
| Terbinafine | 94 | ||
| Echinocandins | 94 | ||
| Other Antifungal Treatments | 94 | ||
| SUGGESTED READINGS | 94 | ||
| REFERENCES | 95 | ||
| Chapter 10 - Antiprotozoal Drugs | 97 | ||
| INTRODUCTION | 97 | ||
| Antiprotozoal Drugs Used Primarily for Gastrointestinal Infections | 97 | ||
| Antibacterial Drugs with Broad-Spectrum Antiprotozoal Activity | 99 | ||
| Antiprotozoal Drugs Used for Systemic Protozoal Infections | 99 | ||
| Antileishmanial Antiprotozoal Drugs | 101 | ||
| SUGGESTED READING | 103 | ||
| REFERENCES | 103 | ||
| SECTION 3 -\rBasic Principles for Infection Control | 105 | ||
| Chapter 11 - Infection Control Programs for Dogs and Cats | 105 | ||
| INTRODUCTION | 105 | ||
| Infection Control Programs | 105 | ||
| The Hospital Infection Control Protocol | 105 | ||
| Standard Precautions | 106 | ||
| Immunocompromised People and Children | 114 | ||
| Transmissible Disease Surveillance and Reporting | 114 | ||
| Surgical Preparation | 115 | ||
| Antimicrobial Drug Use | 116 | ||
| Prevention of Infectious Disease in Shelters and Breeding and Boarding Facilities | 116 | ||
| SUGGESTED READINGS | 117 | ||
| REFERENCES | 117 | ||
| Chapter 12 - Immunization | 119 | ||
| INTRODUCTION | 119 | ||
| Vaccine Composition and Types of Vaccines | 119 | ||
| Vaccine Storage, Handling, and Administration | 120 | ||
| Components of the Immune Response | 121 | ||
| Determinants of Immunogenicity | 122 | ||
| Measurement of the Immune Response | 122 | ||
| Adverse Reactions to Vaccines | 124 | ||
| Vaccine Selection | 128 | ||
| SUGGESTED READINGS | 128 | ||
| REFERENCES | 128 | ||
| PART II -\rMajor Infectious Diseases andTheir Etiologic Agents | 131 | ||
| SECTION 1 -\rViral Diseases | 132 | ||
| Chapter 13 - Rabies | 132 | ||
| Etiologic Agent and Epidemiology | 132 | ||
| Clinical Features | 134 | ||
| Diagnosis | 135 | ||
| Treatment and Prognosis | 137 | ||
| Immunity and Vaccination | 137 | ||
| Prevention | 138 | ||
| Public Health Aspects | 139 | ||
| SUGGESTED READINGS | 139 | ||
| REFERENCES | 139 | ||
| Chapter 14 - Canine Parvovirus Infections and Other Viral Enteritides | 141 | ||
| Etiology and Epidemiology | 141 | ||
| Clinical Features | 141 | ||
| Diagnosis | 143 | ||
| Treatment and Prognosis | 146 | ||
| Immunity and Vaccination | 148 | ||
| Prevention | 149 | ||
| Public Health Aspects | 149 | ||
| SUGGESTED READINGS | 150 | ||
| REFERENCES | 150 | ||
| Chapter 15 - Canine Distemper Virus Infection | 152 | ||
| Etiology and Epidemiology | 152 | ||
| Clinical Features | 153 | ||
| Diagnosis | 156 | ||
| Treatment and Prognosis | 160 | ||
| Immunity and Vaccination | 161 | ||
| Prevention | 161 | ||
| Public Health Aspects | 162 | ||
| SUGGESTED READINGS | 164 | ||
| REFERENCES | 164 | ||
| Chapter 16 - Canine Herpesvirus Infection | 166 | ||
| Etiology and Epidemiology | 166 | ||
| Clinical Features | 166 | ||
| Diagnosis | 166 | ||
| Treatment | 167 | ||
| Immunity, Vaccination, and Prevention | 168 | ||
| Public Health Aspects | 168 | ||
| REFERENCES | 169 | ||
| Chapter 17 - Canine Viral Respiratory Infections | 170 | ||
| Etiology and Epidemiology | 170 | ||
| Clinical Features | 173 | ||
| Diagnosis | 174 | ||
| Treatment and Prognosis | 176 | ||
| Immunity and Vaccination | 177 | ||
| Prevention | 177 | ||
| Public Health Aspects | 178 | ||
| SUGGESTED READINGS | 179 | ||
| REFERENCES | 179 | ||
| Chapter 18 - Infectious Canine Hepatitis | 182 | ||
| Etiology and Epidemiology | 182 | ||
| Clinical Features | 182 | ||
| Diagnosis | 184 | ||
| Treatment and Prognosis | 185 | ||
| Immunity and Vaccination | 186 | ||
| Prevention | 186 | ||
| Public Health Aspects | 186 | ||
| SUGGESTED READINGS | 186 | ||
| REFERENCES | 186 | ||
| Chapter 19 - Feline Panleukopenia Virus Infection and Other Viral Enteritides | 187 | ||
| Etiology and Epidemiology | 187 | ||
| Clinical Features | 187 | ||
| Diagnosis | 188 | ||
| Treatment and Prognosis | 191 | ||
| Immunity and Vaccination | 191 | ||
| Prevention | 192 | ||
| Public Health Aspects | 192 | ||
| SUGGESTED READINGS | 193 | ||
| REFERENCES | 193 | ||
| Chapter 20 - Feline Coronavirus Infection | 195 | ||
| Etiology and Epidemiology | 195 | ||
| Clinical Features | 196 | ||
| Diagnosis | 198 | ||
| Treatment and Prognosis | 203 | ||
| Immunity and Vaccination | 204 | ||
| Prevention | 205 | ||
| Public Health Aspects | 205 | ||
| REFERENCES | 207 | ||
| Chapter 21 - Feline Immunodeficiency Virus Infection | 209 | ||
| Etiology and Epidemiology | 209 | ||
| Clinical Features | 210 | ||
| Diagnosis | 214 | ||
| Treatment and Prognosis | 216 | ||
| Immunity and Vaccination | 218 | ||
| Prevention | 218 | ||
| Public Health Aspects | 218 | ||
| SUGGESTED READINGS | 220 | ||
| REFERENCES | 220 | ||
| Chapter 22 - Feline Leukemia Virus Infection | 224 | ||
| Etiology and Epidemiology | 224 | ||
| Clinical Features | 225 | ||
| Diagnosis | 229 | ||
| Treatment and Prognosis | 232 | ||
| Immunity and Vaccination | 233 | ||
| Prevention | 234 | ||
| Public Health Aspects | 234 | ||
| SUGGESTED READINGS | 235 | ||
| REFERENCES | 235 | ||
| Chapter 23 - Feline Respiratory Viral Infections | 239 | ||
| Etiology and Epidemiology | 239 | ||
| Clinical Features | 240 | ||
| Diagnosis | 243 | ||
| Treatment and Prognosis | 246 | ||
| Immunity and Vaccination | 247 | ||
| Prevention | 248 | ||
| Public Health Aspects | 248 | ||
| SUGGESTED READINGS | 249 | ||
| REFERENCES | 249 | ||
| Chapter 24 - Feline Poxvirus Infections | 252 | ||
| Etiology and Epidemiology | 252 | ||
| Clinical Features | 253 | ||
| Diagnosis | 253 | ||
| Treatment and Prognosis | 255 | ||
| Prevention | 255 | ||
| Public Health Aspects | 255 | ||
| SUGGESTED READINGS | 255 | ||
| REFERENCES | 255 | ||
| Chapter 25 - Pseudorabies | 257 | ||
| Etiology and Epidemiology | 257 | ||
| Clinical Features | 257 | ||
| Diagnosis | 258 | ||
| Treatment and Prognosis | 259 | ||
| Immunity and Vaccination | 259 | ||
| Prevention | 259 | ||
| Public Health Aspects | 260 | ||
| SUGGESTED READINGS | 260 | ||
| REFERENCES | 260 | ||
| Chapter 26 - Viral Papillomatosis | 261 | ||
| Etiology and Epidemiology | 261 | ||
| Clinical Features | 262 | ||
| Physical Examination | 262 | ||
| Diagnosis | 263 | ||
| Treatment and Prognosis | 265 | ||
| Immunity and Vaccination | 265 | ||
| Prevention | 265 | ||
| Public Health Aspects | 266 | ||
| SUGGESTED READING | 267 | ||
| REFERENCES | 267 | ||
| Chapter 27 - Vector-borne and Other Viral Encephalitides | 269 | ||
| Etiology, Epidemiology, and Clinical Features | 269 | ||
| Diagnosis | 273 | ||
| Treatment and Prognosis | 274 | ||
| Immunity and Vaccination | 274 | ||
| Prevention | 274 | ||
| Public Health Aspects | 275 | ||
| SUGGESTED READINGS | 276 | ||
| REFERENCES | 276 | ||
| SECTION 2 -\rBacterial Diseases | 278 | ||
| Chapter 28 - Ehrlichiosis | 278 | ||
| Ehrlichia canis Infection | 279 | ||
| Etiology and Epidemiology | 279 | ||
| Clinical Features | 280 | ||
| Diagnosis | 280 | ||
| Treatment and Prognosis | 283 | ||
| Immunity and Vaccination | 284 | ||
| Prevention | 284 | ||
| Public Health Aspects | 284 | ||
| Ehrlichia ewingii Infection | 284 | ||
| Etiology and Epidemiology | 284 | ||
| Clinical Features | 284 | ||
| Diagnosis | 285 | ||
| Treatment and Prognosis | 285 | ||
| Prevention | 285 | ||
| Public Health Aspects | 285 | ||
| Ehrlichia chaffeensis Infection | 285 | ||
| Ehrlichia muris-like Infection | 285 | ||
| SUGGESTED READINGS | 287 | ||
| REFERENCES | 287 | ||
| Chapter 29 - Anaplasmosis | 290 | ||
| Anaplasma phagocytophilum Infection | 290 | ||
| Etiology and Epidemiology | 290 | ||
| Clinical Features | 291 | ||
| Diagnosis | 292 | ||
| Treatment and Prognosis | 295 | ||
| Immunity and Vaccination | 295 | ||
| Prevention | 295 | ||
| Public Health Aspects | 295 | ||
| Anaplasma platys Infection | 295 | ||
| Etiologic Agent and Epidemiology | 295 | ||
| Clinical Features | 296 | ||
| Diagnosis | 296 | ||
| Treatment and Prognosis | 296 | ||
| Prevention | 297 | ||
| Public Health Aspects | 297 | ||
| SUGGESTED READING | 298 | ||
| REFERENCES | 298 | ||
| Chapter 30 - Rocky Mountain Spotted Fever | 300 | ||
| Etiologic Agent | 300 | ||
| Epidemiology | 301 | ||
| Clinical Features | 303 | ||
| Diagnosis | 304 | ||
| Treatment | 306 | ||
| Immunity and Vaccination | 307 | ||
| Prevention | 307 | ||
| Public Health Aspects | 307 | ||
| SUGGESTED READINGS | 309 | ||
| REFERENCES | 309 | ||
| Chapter 31 - Salmon Poisoning Disease | 311 | ||
| Etiologic Agent and Epidemiology | 311 | ||
| Clinical Features | 312 | ||
| Diagnosis | 313 | ||
| Treatment and Prognosis | 316 | ||
| Immunity and Vaccination | 317 | ||
| Prevention | 317 | ||
| Public Health Aspects | 317 | ||
| SUGGESTED READINGS | 319 | ||
| REFERENCES | 319 | ||
| Chapter 32 - Coxiellosis and Q Fever | 320 | ||
| Clinical Features | 321 | ||
| Diagnosis | 321 | ||
| Treatment | 322 | ||
| Public Health Aspects | 323 | ||
| SUGGESTED READINGS | 325 | ||
| REFERENCES | 325 | ||
| Chapter 33 - Chlamydial Infections | 326 | ||
| Etiology Agent and Epidemiology | 326 | ||
| Clinical Features | 327 | ||
| Diagnosis | 328 | ||
| Treatment and Prognosis | 330 | ||
| Immunity and Vaccination | 331 | ||
| Prevention | 331 | ||
| Public Health Aspects | 331 | ||
| SUGGESTED READINGS | 332 | ||
| REFERENCES | 332 | ||
| Chapter 34 - Streptococcal and Enterococcal Infections | 334 | ||
| Etiology, Epidemiology, and Clinical Features | 334 | ||
| Diagnosis | 339 | ||
| Treatment and Prognosis | 340 | ||
| Prevention | 342 | ||
| Public Health Aspects | 342 | ||
| SUGGESTED READINGS | 344 | ||
| REFERENCES | 344 | ||
| Chapter 35 - Staphylococcus Infections | 347 | ||
| Etiology and Epidemiology | 347 | ||
| Clinical Features | 349 | ||
| Diagnosis | 349 | ||
| Treatment and Prognosis | 350 | ||
| Prevention | 351 | ||
| Public Health Aspects | 351 | ||
| SUGGESTED READING | 354 | ||
| REFERENCES | 354 | ||
| Chapter 36 - Gram-negative Bacterial Infections | 355 | ||
| Etiology, Epidemiology, and Clinical Features | 355 | ||
| Diagnosis | 359 | ||
| Treatment and Prognosis | 360 | ||
| Prevention | 360 | ||
| Public Health Aspects | 360 | ||
| SUGGESTED READINGS | 362 | ||
| REFERENCES | 362 | ||
| Chapter 37 - Anaerobic Bacterial Infections | 364 | ||
| Etiology and Epidemiology | 364 | ||
| Clinical Features | 364 | ||
| Diagnosis | 367 | ||
| Treatment and Prognosis | 368 | ||
| Prevention | 368 | ||
| Public Health Aspects | 368 | ||
| SUGGESTED READING | 370 | ||
| REFERENCES | 370 | ||
| Chapter 38 - Bordetellosis | 372 | ||
| Etiologic Agent and Epidemiology | 372 | ||
| Clinical Features | 373 | ||
| Diagnosis | 374 | ||
| Treatment and Prognosis | 375 | ||
| Immunity and Vaccination | 376 | ||
| Prevention | 376 | ||
| Public Health Aspects | 376 | ||
| SUGGESTED READINGS | 377 | ||
| REFERENCES | 377 | ||
| Chapter 39 - Cell Wall–Deficient Bacterial Infections | 380 | ||
| Etiologic Agent and Epidemiology | 380 | ||
| Clinical Features | 380 | ||
| Diagnosis | 380 | ||
| Treatment and Prognosis | 381 | ||
| Public Health Aspects | 381 | ||
| SUGGESTED READINGS | 381 | ||
| REFERENCES | 381 | ||
| Chapter 40 - Mycoplasma Infections | 382 | ||
| Etiology and Epidemiology | 382 | ||
| Clinical Features | 383 | ||
| Diagnosis | 384 | ||
| Treatment and Prognosis | 386 | ||
| Immunity and Vaccination | 386 | ||
| Prevention | 386 | ||
| Public Health Aspects | 387 | ||
| SUGGESTED READINGS | 388 | ||
| REFERENCES | 388 | ||
| Chapter 41 - Hemoplasma Infections | 390 | ||
| Etiology and Epidemiology | 390 | ||
| Clinical Features | 392 | ||
| Diagnosis | 393 | ||
| Treatment and Prognosis | 394 | ||
| Immunity and Vaccination | 395 | ||
| Prevention | 395 | ||
| Public Health Aspects | 395 | ||
| SUGGESTED READINGS | 397 | ||
| REFERENCES | 397 | ||
| Chapter 42 - Actinomycosis | 399 | ||
| Etiology and Epidemiology | 399 | ||
| Clinical Features | 399 | ||
| Diagnosis | 402 | ||
| Treatment and Prognosis | 404 | ||
| Prevention | 405 | ||
| Public Health Aspects | 405 | ||
| SUGGESTED READINGS | 407 | ||
| REFERENCES | 407 | ||
| Chapter 43 - Nocardiosis | 409 | ||
| Etiology and Epidemiology | 409 | ||
| Clinical Features | 410 | ||
| Diagnosis | 411 | ||
| Treatment and Prognosis | 413 | ||
| Immunity and Vaccination | 415 | ||
| Prevention | 415 | ||
| Public Health Aspects | 415 | ||
| SUGGESTED READINGS | 416 | ||
| REFERENCES | 416 | ||
| Chapter 44 - Mycobacterial Infections | 418 | ||
| Mycobacterium tuberculosis Complex | 418 | ||
| Clinical Features | 420 | ||
| Diagnosis | 421 | ||
| Treatment and Prognosis | 424 | ||
| Immunity and Vaccination | 425 | ||
| Prevention | 425 | ||
| Public Health Aspects | 425 | ||
| Mycobacterium avium Complex | 426 | ||
| Etiology and Epidemiology | 426 | ||
| Clinical Features | 427 | ||
| Diagnosis | 427 | ||
| Treatment and Prognosis | 428 | ||
| Public Health Aspects | 428 | ||
| Lepromatous Mycobacteria | 429 | ||
| Etiology and Epidemiology | 429 | ||
| Clinical Features | 429 | ||
| Diagnosis | 430 | ||
| Treatment | 430 | ||
| Prevention and Public Health Aspects | 430 | ||
| Nontuberculous Bacteria Other Than Mycobacterium avium-intracellulare | 430 | ||
| Etiology and Epidemiology | 430 | ||
| Clinical Features | 431 | ||
| Diagnosis | 432 | ||
| Treatment and Prognosis | 432 | ||
| Public Health Aspects | 433 | ||
| SUGGESTED READINGS | 434 | ||
| REFERENCES | 434 | ||
| Chapter 45 - Salmonellosis | 437 | ||
| Etiology and Epidemiology | 437 | ||
| Clinical Features | 438 | ||
| Diagnosis | 439 | ||
| Treatment and Prognosis | 440 | ||
| Immunity and Vaccination | 440 | ||
| Prevention of Enteric Bacterial Infections | 440 | ||
| Public Health Aspects | 440 | ||
| SUGGESTED READINGS | 443 | ||
| REFERENCES | 443 | ||
| Chapter 46 - Enteric Escherichia coli Infections | 445 | ||
| Etiology and Epidemiology | 445 | ||
| Clinical Features | 445 | ||
| Diagnosis | 447 | ||
| Treatment and Prognosis | 448 | ||
| Immunity and Vaccination | 448 | ||
| Prevention | 448 | ||
| Public Health Aspects | 448 | ||
| SUGGESTED READINGS | 450 | ||
| REFERENCES | 450 | ||
| Chapter 47 - Campylobacteriosis | 452 | ||
| Etiology and Epidemiology | 452 | ||
| Clinical Features | 452 | ||
| Diagnosis | 453 | ||
| Treatment and Prognosis | 454 | ||
| Immunity and Vaccination | 455 | ||
| Public Health Aspects | 455 | ||
| SUGGESTED READINGS | 457 | ||
| REFERENCES | 457 | ||
| Chapter 48 - Enteric Clostridial Infections | 458 | ||
| Etiology and Epidemiology | 458 | ||
| Clinical Features | 459 | ||
| Diagnosis | 459 | ||
| Treatment and Prognosis | 461 | ||
| Immunity and Vaccination | 461 | ||
| Public Health Aspects | 461 | ||
| SUGGESTED READINGS | 463 | ||
| REFERENCES | 463 | ||
| Chapter 49 - Gastric Helicobacter-like Infections | 465 | ||
| Etiology and Epidemiology | 465 | ||
| Clinical Features | 466 | ||
| Diagnosis | 466 | ||
| Treatment and Prognosis | 468 | ||
| Immunity and Vaccination | 470 | ||
| Public Health Aspects | 470 | ||
| SUGGESTED READING | 472 | ||
| REFERENCES | 472 | ||
| Chapter 50 - Leptospirosis | 474 | ||
| Etiologic Agent and Epidemiology | 474 | ||
| Clinical Features | 475 | ||
| Diagnosis | 476 | ||
| Treatment and Prognosis | 480 | ||
| Immunity and Vaccination | 482 | ||
| Prevention | 482 | ||
| Public Health Aspects | 483 | ||
| SUGGESTED READINGS | 485 | ||
| REFERENCES | 485 | ||
| Chapter 51 - Lyme Borreliosis | 487 | ||
| Etiologic Agent and Epidemiology | 487 | ||
| Clinical Features | 489 | ||
| Diagnosis | 489 | ||
| Treatment and Prognosis | 492 | ||
| Immunity and Vaccination | 494 | ||
| Prevention | 494 | ||
| Public Health Aspects | 494 | ||
| SUGGESTED READINGS | 496 | ||
| REFERENCES | 496 | ||
| Chapter 52 - Bartonellosis | 498 | ||
| Etiology and Epidemiology | 498 | ||
| Clinical Features | 499 | ||
| Diagnosis | 502 | ||
| Treatment and Prognosis | 505 | ||
| Immunity and Vaccination | 506 | ||
| Prevention | 506 | ||
| Public Health Aspects | 506 | ||
| SUGGESTED READINGS | 509 | ||
| REFERENCES | 509 | ||
| Chapter 53 - Canine Brucellosis | 512 | ||
| Etiology and Epidemiology | 512 | ||
| Clinical Features | 512 | ||
| Diagnosis | 514 | ||
| Treatment and Prognosis | 517 | ||
| Vaccination and Immunity | 517 | ||
| Prevention | 517 | ||
| Public Health Aspects | 517 | ||
| SUGGESTED READINGS | 519 | ||
| REFERENCES | 519 | ||
| Chapter 54 - Tetanus and Botulism | 520 | ||
| Etiology and Epidemiology | 520 | ||
| Clinical Features | 520 | ||
| Diagnosis | 524 | ||
| Treatment and Prognosis | 525 | ||
| Immunity and Vaccination | 527 | ||
| Prevention | 527 | ||
| Public Health Aspects | 527 | ||
| SUGGESTED READINGS | 529 | ||
| REFERENCES | 529 | ||
| Chapter 55 - Yersinia pestis (Plague) and Other Yersinioses | 531 | ||
| Etiology and Epidemiology | 531 | ||
| Clinical Features | 532 | ||
| Diagnosis | 533 | ||
| Treatment and Prognosis | 534 | ||
| Immunity and Vaccination | 535 | ||
| Prevention | 535 | ||
| Public Health Aspects | 535 | ||
| Other Yersinioses | 535 | ||
| SUGGESTED READINGS | 536 | ||
| REFERENCES | 536 | ||
| Chapter 56 - Tularemia | 537 | ||
| Etiologic Agent and Epidemiology | 537 | ||
| Clinical Features | 538 | ||
| Diagnosis | 539 | ||
| Treatment and Prognosis | 541 | ||
| Immunity and Vaccination | 541 | ||
| Prevention | 542 | ||
| Public Health Aspects | 542 | ||
| SUGGESTED READINGS | 544 | ||
| REFERENCES | 544 | ||
| Chapter 57 - Bite and Scratch Wound Infections | 546 | ||
| Etiology and Epidemiology | 546 | ||
| Clinical Features | 547 | ||
| Diagnosis | 550 | ||
| Treatment and Prognosis | 551 | ||
| Prevention | 553 | ||
| Public Health Aspects | 553 | ||
| SUGGESTED READINGS | 557 | ||
| REFERENCES | 557 | ||
| SECTION 3 -\rFungal and Algal Diseases | 558 | ||
| Chapter 58 - Dermatophytosis | 558 | ||
| Etiology and Epidemiology | 558 | ||
| Clinical Features | 559 | ||
| Diagnosis | 561 | ||
| Treatment and Prognosis | 564 | ||
| Immunity and Vaccination | 566 | ||
| Prevention | 566 | ||
| Public Health Aspects | 566 | ||
| SUGGESTED READINGS | 568 | ||
| REFERENCES | 568 | ||
| Chapter 59 - Malassezia Infections | 570 | ||
| Etiology and Epidemiology | 570 | ||
| Clinical Features | 570 | ||
| Diagnosis | 571 | ||
| Treatment and Prognosis | 572 | ||
| Public Health Aspects | 572 | ||
| SUGGESTED READING | 572 | ||
| REFERENCES | 572 | ||
| Chapter 60 - Blastomycosis | 574 | ||
| Etiology and Epidemiology | 574 | ||
| Clinical Features | 575 | ||
| Diagnosis | 577 | ||
| Treatment and Prognosis | 581 | ||
| Immunity and Vaccination | 582 | ||
| Prevention | 582 | ||
| Public Health Aspects | 582 | ||
| SUGGESTED READINGS | 584 | ||
| REFERENCES | 584 | ||
| Chapter 61 - Histoplasmosis | 587 | ||
| Etiology and Epidemiology | 587 | ||
| Clinical Features | 587 | ||
| Diagnosis | 590 | ||
| Treatment and Prognosis | 592 | ||
| Immunity and Vaccination | 593 | ||
| Prevention | 594 | ||
| Public Health Aspects | 594 | ||
| SUGGESTED READINGS | 597 | ||
| REFERENCES | 597 | ||
| Chapter 62 - Cryptococcosis | 599 | ||
| Etiology and Epidemiology | 599 | ||
| Clinical Features | 601 | ||
| Diagnosis | 604 | ||
| Treatment and Prognosis | 608 | ||
| Immunity and Vaccination | 609 | ||
| Prevention | 609 | ||
| Public Health Aspects | 609 | ||
| SUGGESTED READINGS | 611 | ||
| REFERENCES | 611 | ||
| Chapter 63 - Coccidioidomycosis | 613 | ||
| Etiology and Epidemiology | 613 | ||
| Clinical Features | 614 | ||
| Diagnosis | 615 | ||
| Treatment and Prognosis | 620 | ||
| Immunity and Vaccination | 621 | ||
| Prevention | 621 | ||
| Public Health Aspects | 621 | ||
| SUGGESTED READINGS | 622 | ||
| REFERENCES | 622 | ||
| Chapter 64 - Sporotrichosis | 624 | ||
| Etiology and Epidemiology | 624 | ||
| Clinical Features | 624 | ||
| Diagnosis | 626 | ||
| Treatment and Prognosis | 629 | ||
| Immunity and Vaccination | 629 | ||
| Prevention | 629 | ||
| Public Health Aspects | 629 | ||
| SUGGESTED READINGS | 631 | ||
| REFERENCES | 631 | ||
| Chapter 65 - Aspergillosis | 633 | ||
| Upper Respiratory Tract Aspergillosis | 633 | ||
| Etiology and Epidemiology | 633 | ||
| Clinical Features | 634 | ||
| Diagnosis | 635 | ||
| Treatment and Prognosis | 638 | ||
| Public Health Aspects | 639 | ||
| Systemic Aspergillosis | 639 | ||
| Etiology and Epidemiology | 639 | ||
| Clinical Features | 640 | ||
| Diagnosis | 641 | ||
| Treatment and Prognosis | 644 | ||
| Immunity and Vaccination | 645 | ||
| Public Health Aspects | 645 | ||
| KERATOMYCOSIS AND OTOMYCOSIS CAUSED BY ASPERGILLUS SPECIES | 645 | ||
| SUGGESTED READINGS | 647 | ||
| REFERENCES | 647 | ||
| Chapter 66 - Rhinosporidiosis | 649 | ||
| Etiology and Epidemiology | 649 | ||
| Clinical Features | 649 | ||
| Diagnosis | 650 | ||
| Treatment and Prognosis | 650 | ||
| Public Health Aspects | 651 | ||
| SUGGESTED READING | 652 | ||
| REFERENCES | 652 | ||
| Chapter 67 - Candidiasis | 653 | ||
| Etiology and Epidemiology | 653 | ||
| Clinical Features | 653 | ||
| Diagnosis | 655 | ||
| Treatment and Prognosis | 656 | ||
| Prevention | 656 | ||
| Public Health Aspects | 656 | ||
| SUGGESTED READINGS | 658 | ||
| REFERENCES | 658 | ||
| Chapter 68 - Miscellaneous Fungal Diseases | 660 | ||
| Phaeohyphomycosis | 660 | ||
| Clinical Features | 660 | ||
| Diagnosis | 661 | ||
| Treatment and Prognosis | 662 | ||
| Public Health Aspects | 663 | ||
| Hyalohyphomycosis | 663 | ||
| Clinical Features | 663 | ||
| Diagnosis | 664 | ||
| Treatment and Prognosis | 664 | ||
| Public Health Aspects | 665 | ||
| Eumycotic Mycetoma | 665 | ||
| SUGGESTED READINGS | 666 | ||
| REFERENCES | 666 | ||
| Chapter 69 - Pythiosis, Lagenidiosis, and Zygomycosis | 668 | ||
| PYTHIOSIS | 668 | ||
| Etiology and Epidemiology | 668 | ||
| Clinical Features | 668 | ||
| Diagnosis | 670 | ||
| Treatment and Prognosis | 671 | ||
| Public Health Aspects | 672 | ||
| LAGENIDIOSIS | 672 | ||
| Etiology and Epidemiology | 672 | ||
| Clinical Features | 672 | ||
| Diagnosis | 673 | ||
| Treatment and Prognosis | 674 | ||
| Public Health Aspects | 674 | ||
| ZYGOMYCOSIS | 674 | ||
| Etiology and Epidemiology | 674 | ||
| Clinical Features | 675 | ||
| Diagnosis | 675 | ||
| Treatment and Prognosis | 676 | ||
| Public Health Aspects | 676 | ||
| SUGGESTED READINGS | 678 | ||
| REFERENCES | 678 | ||
| Chapter 70 - Protothecosis | 679 | ||
| Etiology and Epidemiology | 679 | ||
| Clinical Features | 680 | ||
| Diagnosis | 680 | ||
| Treatment and Prognosis | 683 | ||
| Public Health Aspects | 683 | ||
| SUGGESTED READINGS | 685 | ||
| REFERENCES | 685 | ||
| Chapter 71 - Pneumocystosis | 686 | ||
| Etiologic Agent and Epidemiology | 686 | ||
| Clinical Features | 686 | ||
| Diagnosis | 688 | ||
| Treatment and Prognosis | 690 | ||
| Public Health Aspects | 691 | ||
| SUGGESTED READINGS | 691 | ||
| REFERENCES | 691 | ||
| SECTION 4 -\rProtozoal Diseases | 693 | ||
| Chapter 72 - Toxoplasmosis | 693 | ||
| Etiologic Agent and Epidemiology | 693 | ||
| Clinical Features | 694 | ||
| Diagnosis | 695 | ||
| Treatment and Prognosis | 699 | ||
| Immunity and Vaccination | 700 | ||
| Prevention | 700 | ||
| Public Health Aspects | 700 | ||
| SUGGESTED READINGS | 701 | ||
| REFERENCES | 701 | ||
| Chapter 73 - Neosporosis | 704 | ||
| Etiology and Epidemiology | 704 | ||
| Clinical Features | 705 | ||
| Diagnosis | 706 | ||
| Treatment and Prognosis | 708 | ||
| Immunity and Vaccination | 709 | ||
| Prevention | 709 | ||
| Public Health Aspects | 709 | ||
| SUGGESTED READINGS | 711 | ||
| REFERENCES | 711 | ||
| Chapter 74 - Leishmaniosis | 713 | ||
| CANINE LEISHMANIOSIS | 713 | ||
| Clinical Features | 715 | ||
| Diagnosis | 716 | ||
| Treatment and Prognosis | 719 | ||
| Immunity and Vaccination | 720 | ||
| Prevention | 721 | ||
| Public Health Aspects | 721 | ||
| FELINE LEISHMANIOSIS | 721 | ||
| SUGGESTED READINGS | 723 | ||
| REFERENCES | 723 | ||
| Chapter 75 - Babesiosis | 727 | ||
| Etiology and Epidemiology | 727 | ||
| Clinical Features | 729 | ||
| Diagnosis | 730 | ||
| Treatment and Prognosis | 733 | ||
| Immunity and Vaccination | 735 | ||
| Prevention | 735 | ||
| Public Health Aspects | 735 | ||
| SUGGESTED READINGS | 736 | ||
| REFERENCES | 736 | ||
| Chapter 76 - Cytauxzoonosis | 739 | ||
| Etiology and Epidemiology | 739 | ||
| Clinical Features | 739 | ||
| Diagnosis | 740 | ||
| Treatment and Prognosis | 743 | ||
| Immunity and Vaccination | 744 | ||
| Prevention | 744 | ||
| Public Health Aspects | 744 | ||
| SUGGESTED READINGS | 745 | ||
| REFERENCES | 745 | ||
| Chapter 77 - Canine and Feline Hepatozoonosis | 747 | ||
| Etiology and Epidemiology | 747 | ||
| Clinical Features | 750 | ||
| Diagnosis | 752 | ||
| Treatment and Prognosis | 754 | ||
| Immunity and Vaccination | 755 | ||
| Prevention | 755 | ||
| Public Health Aspects | 755 | ||
| Hepatozoonosis in Domestic Cats | 756 | ||
| SUGGESTED READINGS | 757 | ||
| REFERENCES | 757 | ||
| Chapter 78 - Trypanosomiasis | 760 | ||
| AMERICAN TRYPANOSOMIASIS | 760 | ||
| Clinical Features | 762 | ||
| Diagnosis | 762 | ||
| Treatment and Prognosis | 765 | ||
| Immunity and Vaccination | 766 | ||
| Prevention | 766 | ||
| Public Health Aspects | 766 | ||
| AFRICAN TRYPANOSOMIASIS | 767 | ||
| OTHER TRYPANOSOMA INFECTIONS | 768 | ||
| SUGGESTED READINGS | 769 | ||
| REFERENCES | 769 | ||
| Chapter 79 - Giardiasis | 771 | ||
| Etiologic Agent and Epidemiology | 771 | ||
| Clinical Features | 772 | ||
| Diagnosis | 773 | ||
| Treatment and Prognosis | 775 | ||
| Immunity and Vaccination | 776 | ||
| Prevention | 776 | ||
| Public Health Aspects | 776 | ||
| SUGGESTED READINGS | 777 | ||
| REFERENCES | 777 | ||
| Chapter 80 - Trichomoniasis | 779 | ||
| Etiologic Agent and Epidemiology | 779 | ||
| Clinical Features | 780 | ||
| Diagnosis | 781 | ||
| Treatment and Prognosis | 781 | ||
| Immunity and Vaccination | 782 | ||
| Prevention | 782 | ||
| Public Health Aspects | 782 | ||
| SUGGESTED READINGS | 783 | ||
| REFERENCES | 783 | ||
| Chapter 81 - Cryptosporidiosis | 785 | ||
| Etiologic Agent and Epidemiology | 785 | ||
| Clinical Features | 785 | ||
| Physical Examination Findings | 787 | ||
| Diagnosis | 787 | ||
| Treatment and Prognosis | 788 | ||
| Immunity and Vaccination | 789 | ||
| Prevention | 789 | ||
| Public Health Aspects | 789 | ||
| SUGGESTED READING | 791 | ||
| REFERENCES | 791 | ||
| Chapter 82 - Isosporiasis | 793 | ||
| Etiologic Agent and Epidemiology | 793 | ||
| Clinical Features | 793 | ||
| Diagnosis | 793 | ||
| Treatment and Prognosis | 795 | ||
| Immunity and Vaccination | 795 | ||
| Prevention | 795 | ||
| Public Health Aspects | 796 | ||
| SUGGESTED READING | 796 | ||
| REFERENCES | 796 | ||
| Chapter 83 - Miscellaneous Protozoal Diseases | 797 | ||
| MISCELLANEOUS SYSTEMIC PROTOZOAL INFECTIONS | 797 | ||
| Sarcocystosis | 797 | ||
| Rangeliosis and Theileriosis | 797 | ||
| Systemic Amebiasis | 798 | ||
| MISCELLANEOUS GASTROINTESTINAL PROTOZOAL INFECTIONS | 798 | ||
| SUGGESTED READINGS | 798 | ||
| REFERENCES | 798 | ||
| SECTION 5 -\rInfections of Selected Organ Systems | 800 | ||
| Chapter 84 - Pyoderma, Otitis Externa, and Otitis Media | 800 | ||
| PYODERMA | 800 | ||
| Etiology and Epidemiology | 800 | ||
| Clinical Features | 801 | ||
| Diagnosis | 802 | ||
| Treatment and Prognosis | 803 | ||
| Prevention | 804 | ||
| Public Health Aspects | 804 | ||
| OTITIS EXTERNA AND OTITIS MEDIA | 805 | ||
| Clinical Features | 806 | ||
| Diagnosis | 806 | ||
| Treatment and Prognosis | 808 | ||
| Public Health Aspects | 811 | ||
| SUGGESTED READINGS | 812 | ||
| REFERENCES | 812 | ||
| Chapter 85 - Osteomyelitis, Discospondylitis, and Infectious Arthritis | 814 | ||
| OSTEOMYELITIS | 814 | ||
| Clinical Features | 815 | ||
| Diagnosis | 816 | ||
| Treatment and Prognosis | 817 | ||
| Prevention | 819 | ||
| Public Health Aspects | 820 | ||
| DISCOSPONDYLITIS | 820 | ||
| Clinical Features | 821 | ||
| Diagnosis | 821 | ||
| Treatment and Prognosis | 824 | ||
| Public Health Aspects | 825 | ||
| ARTHRITIS | 825 | ||
| Clinical Features | 825 | ||
| Diagnosis | 825 | ||
| Treatment and Prognosis | 826 | ||
| Public Health Aspects | 827 | ||
| SUGGESTED READINGS | 828 | ||
| REFERENCES | 828 | ||
| Chapter 86 - Infections of the Cardiovascular System | 830 | ||
| Etiologic Agents, Epidemiology, and Clinical Features | 830 | ||
| Diagnosis | 835 | ||
| Treatment and Prognosis | 838 | ||
| Prevention | 843 | ||
| Public Health Aspects | 843 | ||
| SUGGESTED READINGS | 845 | ||
| REFERENCES | 845 | ||
| Chapter 87 - Bacterial Bronchopneumonia and Pyothorax | 847 | ||
| BACTERIAL TRACHEOBRONCHITIS AND BRONCHOPNEUMONIA | 847 | ||
| Clinical Features | 848 | ||
| Diagnosis | 849 | ||
| Treatment and Prognosis | 851 | ||
| Prevention | 852 | ||
| Public Health Aspects | 852 | ||
| PYOTHORAX | 852 | ||
| Clinical Features | 853 | ||
| Diagnosis | 853 | ||
| Treatment and Prognosis | 855 | ||
| Prevention | 855 | ||
| SUGGESTED READINGS | 857 | ||
| REFERENCES | 857 | ||
| Chapter 88 - Intra-abdominal Infections | 859 | ||
| INFECTIOUS GASTROENTERITIS | 859 | ||
| BACTERIAL PERITONITIS | 859 | ||
| Clinical Features | 860 | ||
| Diagnosis | 860 | ||
| Treatment and Prognosis | 861 | ||
| HEPATOBILIARY INFECTIONS | 863 | ||
| Clinical Features | 864 | ||
| Diagnosis | 864 | ||
| Treatment and Prognosis | 865 | ||
| HEPATIC ABSCESSES | 865 | ||
| Pancreatitis and Pancreatic Abscesses | 867 | ||
| SUGGESTED READINGS | 869 | ||
| REFERENCES | 869 | ||
| Chapter 89 - Bacterial Infections of the Genitourinary Tract | 871 | ||
| LOWER AND UPPER URINARY TRACT INFECTIONS | 871 | ||
| Clinical Features | 873 | ||
| Diagnosis | 873 | ||
| Treatment and Prognosis | 876 | ||
| Prevention | 877 | ||
| Public Health Aspects | 877 | ||
| ORCHITIS, EPIDIDYMITIS, AND PROSTATITIS | 878 | ||
| Clinical Features | 878 | ||
| Diagnosis | 878 | ||
| Treatment and Prognosis | 879 | ||
| Prevention | 879 | ||
| VAGINITIS, METRITIS, AND PYOMETRA | 879 | ||
| Clinical Features | 880 | ||
| Diagnosis | 880 | ||
| Treatment and Prognosis | 881 | ||
| Prevention | 882 | ||
| SUGGESTED READINGS | 884 | ||
| REFERENCES | 884 | ||
| Chapter 90 - Bacterial Meningitis | 886 | ||
| Etiology and Epidemiology | 886 | ||
| Clinical Features | 886 | ||
| Diagnosis | 887 | ||
| Treatment and Prognosis | 889 | ||
| Prevention | 890 | ||
| Public Health Aspects | 890 | ||
| SUGGESTED READINGS | 891 | ||
| REFERENCES | 891 | ||
| APPENDIX -\rVaccination Schedules for Dogs and Cats | 893 | ||
| Guidelines for Immunization of Dogs and Cats in Shelter Environments | 897 | ||
| REFERENCES | 900 | ||
| Index | 901 | ||
| Abbreviations\r | IBC3 |